Informed choice about breast cancer prevention: Randomized controlled trial of an online decision aid intervention

Breast Cancer Research

Volumn 15, Issue 5, 2013, Pages

  Korfage, Ida J ^a,b   Fuhrel Forbis, Andrea ^b   Ubel, Peter A ^c,d   Zikmund Fisher, Brian J ^b   Greene, Sarah M ^e   McClure, Jennifer B ^e   Smith, Dylan M ^f   Hensley Alford, Sharon ^g   Fagerlin, Angela ^b,h  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MICHIGAN   (United States)

^c DUKE UNIVERSITY   (United States)

^d DUKE UNIVERSITY   (United States)

^e GROUP HEALTH RESEARCH INSTITUTE   (United States)

^f STONY BROOK UNIVERSITY   (United States)

^g HENRY FORD HOSPITAL   (United States)

^h VA Ann Arbor Center for Clinical Management Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RALOXIFENE; TAMOXIFEN; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; BEHAVIOR THERAPY; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG INFORMATION; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INFORMATION DISSEMINATION; KNOWLEDGE; MAJOR CLINICAL STUDY; ONLINE SYSTEM; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COUNSELING; PATIENT DECISION MAKING; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; BEHAVIOR ASSESSMENT; HEALTH EDUCATION; HIGH RISK POPULATION; MEDICAL DECISION MAKING; RISK BENEFIT ANALYSIS; BREAST TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DECISION MAKING; DECISION SUPPORT SYSTEM; INFORMED CONSENT; INTERNET; MIDDLE AGED; PREMEDICATION; RISK FACTOR;

ADULT; AGED; BREAST NEOPLASMS; CHEMOPREVENTION; DECISION MAKING; DECISION SUPPORT TECHNIQUES; FEMALE; FOLLOW-UP STUDIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFORMED CONSENT; INTERNET; MIDDLE AGED; PREMEDICATION; RALOXIFENE; RISK FACTORS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 84883520736     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3468     Document Type: Article

References (31)

1. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998, 90:1371-1388. 10.1093/jnci/90.18.1371, 9747868.
2. Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 2005, 97:1652-1662. 10.1093/jnci/dji372, 16288118.
3. Jordan VC. Tamoxifen: the herald of a new era of preventive therapeutics. J Natl Cancer Inst 1997, 89:747-749. 10.1093/jnci/89.11.747, 9182965.
4. Bober SL, Hoke LA, Duda RB, Regan MM, Tung NM. Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors. J Clin Oncol 2004, 22:4951-4957. 10.1200/JCO.2004.05.192, 15598980.
5. Port E, Montgomery L, Heerdt A, Borgen P. Patient reluctance toward tamoxifen use for breast cancer primary prevention. Ann Surg Oncol 2001, 8:580-585. 10.1007/s10434-001-0580-9, 11508619.
6. Stacey D, O'Connor AM, DeGrasse C, Verma S. Development and evaluation of a breast cancer prevention decision aid for higher-risk women. Health Expect 2003, 6:3-18. 10.1046/j.1369-6513.2003.00195.x, 12603624.
7. Fagerlin A, Zikmund-Fisher BJ, Smith DM, Nair V, Derry HA, McClure JB, Greene S, Stark A, Hensley Alford S, Lantz P, Hayes DF, Wiese C, Claud Zweig S, Pitsch R, Jankovic A, Ubel PA. Women's decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aid. Breast Cancer Res Treat 2010, 119:613-620. 10.1007/s10549-009-0618-4, 3736824, 19908143.
8. Fagerlin A, Dillard AJ, Smith DM, Zikmund-Fisher BJ, Pitsch R, McClure JB, Greene S, Hensley Alford S, Nair V, Hayes DF, Wiese C, Ubel PA. Women's interest in taking tamoxifen and raloxifene for breast cancer prevention: response to a tailored decision aid. Breast Cancer Res Treat 2011, 127:681-688. 10.1007/s10549-011-1450-1, 3742062, 21442198.
9. Kaplan CP, Haas JS, Pérez-Stable EJ, Gregorich SE, Somkin C, Des Jarlais G, Kerlikowske K. Breast cancer risk reduction options: awareness, discussion, and use among women from rour ethnic groups. Cancer Epidemiol Biomarkers Prev 2006, 15:162-166. 10.1158/1055-9965.EPI-04-0758, 16434605.
10. Melnikow J, Paterniti D, Azari R, Kuenneth C, Birch S, Kuppermann M, Nuovo J, Keyzer J, Henderson S. Preferences of women evaluating risks of tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction. Cancer 2005, 103:1996-2005. 10.1002/cncr.20981, 15825209.
11. Metcalfe KA, Snyder C, Seidel J, Hanna D, Lynch HT, Narod S. The use of preventative measures among healthy women who carry BRCA1 or BRCA2 mutation. Fam Cancer 2005, 4:97-103. 10.1007/s10689-005-4215-3, 15951959.
12. Salant T, Ganschow PS, Olopade OI, Lauderdale DS. Why take it if you don't have anything? Breast cancer risk perceptions and prevention choices at a public hospital. J Gen Intern Med 2006, 21:779-785. 10.1111/j.1525-1497.2006.00461.x, 1924720, 16808782.
13. Donovan R, Jalleh G, Jones S. The word 'cancer': reframing the context to reduce anxiety arousal. Aust N Z J Public Health 2003, 7:291-293.
14. Paterniti DA, Melnikow J, Nuovo J, Henderson S, DeGregorio M, Kuppermann M, Nease R. "I'm going to die of something anyway": Women's perceptions of tamoxifen for breast cancer risk reduction. Ethnic Dis 2005, 15:365-372.
15. Promoting Disease Management in Medicare Hearings before the Subcommittee on Health of the House Committee on Ways and Means, 107th Cong, 2nd Sess. 2002, (Testimony of J. E. Wennberg), Promoting Disease Management in Medicare.
16. Osterlie W, Solbjor M, Skolbekken JA, Hofvind S, Saetnan AR, Forsmo S. Challenges of informed choice in organised screening. J Med Ethics 2008, 34:e5. 10.1136/jme.2008.024802, 18757624.
17. Marteau TM, Dormandy E, Michie S. A measure of informed choice. Health Expect 2001, 4:99-108. 10.1046/j.1369-6513.2001.00140.x, 11359540.
18. Michie S, Dormandy E, Marteau TM. The multi-dimensional measure of informed choice: a validation study. Patient Educ Couns 2002, 48:87-91. 10.1016/S0738-3991(02)00089-7, 12220754.
19. O'Connor A, O'Brien-Pallas LL. Decisional conflict. Nursing Diagnosis and Intervention 1989, 573-588. Toronto: C.V. Mosby Company, McFarland GK, McFarlane EA.
20. Gail MH, Brinton LA, Byar DP, Donald K, Green SB, Schairer C, Mulvihill JJ. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989, 81:1879-1886. 10.1093/jnci/81.24.1879, 2593165.
21. Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, Bevers TB, Fehrenbacher L, Pajon ER, Wade JL, Robidoux A, Margolese RG, James J, Lippman SM, Runowicz CD, Ganz PA, Reis SE, McCaskill-Stevens W, Ford LG, Jordan VC, Wolmark N, National Surgical A, Breast Bowel P. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes. JAMA 2006, 295:2727-2741. 10.1001/jama.295.23.joc60074, 16754727.
22. van den Bergh KAM, Essink-Bot M-L, van Klaveren RJ, de Koning HJ. Informed decision making does not affect health-related quality of life in lung cancer screening (NELSON trial). Eur J Cancer 2010, 46:3300-3306. 10.1016/j.ejca.2010.05.030, 20580546.
23. Reyna VF. A theory of medical decision making and health: fuzzy trace theory. Med Decis Making 2008, 28:850-865. 10.1177/0272989X08327066, 2617718, 19015287.
24. Fagerlin A, Zikmund-Fisher BJ, Ubel PA, Jankovic A, Derry HA, Smith DM. Measuring numeracy without a math test: development of the subjective numeracy scale. Med Decis Making 2007, 27:672-680. 10.1177/0272989X07304449, 17641137.
25. Zikmund-Fisher BJ, Smith DM, Ubel PA, Fagerlin A. Validation of the subjective numeracy scale (SNS): effects of low numeracy on comprehension of risk communications and utility elicitations. Med Decis Making 2007, 27:663-671. 10.1177/0272989X07303824, 17652180.
26. Conner M, Sparks P. Ambivalence and attitudes. Eur Rev Soc Psychol 2002, 12:37-70.
27. Stacey D, Bennett CL, Barry MJ, Col NF, Eden KB, Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Legare F, Thomson R. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2011, (10):CD001431.
28. Mathieu E, Barratt A, Davey HM, McGeechan K, Howard K, Houssami N. Informed choice in mammography screening: a randomized trial of a decision aid for 70-year-old women. Arch Intern Med 2007, 167:2039-2046. 10.1001/archinte.167.19.2039, 17954796.
29. Smith SK, Trevena L, Simpson JM, Barratt A, Nutbeam D, McCaffery KJ. A decision aid to support informed choices about bowel cancer screening among adults with low education: randomised controlled trial. BMJ 2010, 341:c5370. 10.1136/bmj.c5370, 2965151, 20978060.
30. Bandilla W, Bosnjak M, Altdorfer P. Survey administration effects?. Soc Sci Computer Rev 2003, 21:235-243.
31. Etter JF, Perneger TV. A comparison of cigarette smokers recruited through the Internet or by mail. Int J Epidemiol 2001, 30:521-5. 10.1093/ije/30.3.521, 11416075.